Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 05.04.2022.

#biotech
#PioneeringForPatients
#cancer
#stocks
#Sales
#Digital
#webinar

Healthcare

@SWLifeSciences shared
On Apr 1, 2022
Biotech Co. Posts Notable PFS Gains in Ph. 3 Cancer Trial: https://t.co/gqqR4VmFuK $CLVS #cancer #biotech #stocks @clovisoncology
Open
Biotech Co. Posts Notable PFS Gains in Ph. 3 Cancer Trial Trending Company

Biotech Co. Posts Notable PFS Gains in Ph. 3 Cancer Trial Trending Company

Clovis Oncology Inc. shares traded 36% higher after the company reported that in the Phase 3 ATHENA-MONO clinical study its Rubraca® (Rucaparib) was shown to significantly improve ...

@SWLifeSciences shared
On Apr 4, 2022
Biopharma Co. Begins Dosing in Ph. 1 Solid Tumor Trial: https://t.co/HqGf9Ddijb $NGM @NGMBio
Open
Biopharma Co. Begins Dosing in Ph. 1 Solid Tumor Trial Trending Company

Biopharma Co. Begins Dosing in Ph. 1 Solid Tumor Trial Trending Company

NGM Biopharmaceuticals Inc. shares rose 14.75% after the company reported it dosed the first group of patients in its Phase 1/1b clinical trial of NGM831 for use in treating advanced solid ...

@Healthcare_GD shared
On Mar 31, 2022
The significant decline in #Sales force interactions has forced a dramatic investment in #Digital spend. Register for our next #webinar for insight into market shifts and strategies: https://t.co/iho1OVSsR1 https://t.co/1iA8g67zEi
Open
Healthcare Digital Landscape

Healthcare Digital Landscape

The significant decline in sales force interactions has forced a dramatic investment in digital spend. GlobalData is on the cutting edge of tracking the marketplace through its ...

@GalapagosGlobal shared
On Apr 1, 2022
As @OvandeStolpe looks back on 23 years at the helm of Galapagos, Paul Stoffels gives a taste of his plans and ambitions for Galapagos' future. The story continues here: https://t.co/TyfYvWJhEW #PioneeringForPatients $glpg https://t.co/hhfcFXtBUh
Open
Foundation & future

Foundation & future

Onno van de Stolpe, retiring CEO of Galapagos ‘The time has come to focus on paradigm-shifting medicines and maximize what we have accomplished’ Over the course of 23 years, we …

@GalapagosGlobal shared
On Mar 30, 2022
4 material aspects have remained the pillars of our Corporate Social Responsibility strategy and action plans in 2021 and ensure that we report on the subjects that matter most. For more on our commitment to CSR at Galapagos: https://t.co/nelc2e3bym #PioneeringForPatients https://t.co/zKwzbL7QSU
Open
Our commitment

Our commitment

Our commitment to Corporate Social Responsibility (CSR) is intrinsically linked to our core mission: to discover and develop novel mechanism of action medicines for diseases with …

@SWLifeSciences shared
On Mar 29, 2022
IGM Biosciences traded 97% higher today after reporting FY/21 results & announcing a partnership w/ Sanofi SA. Biotech Firm's Shares Double on $6B Deal: https://t.co/iDkrHsLyP4 $IGMS $SNY #biotech @igmbio @sanofi https://t.co/S37dLtGjV2
Open
Biotech Firm's Shares Double on $6B Deal Trending Company

Biotech Firm's Shares Double on $6B Deal Trending Company

Shares of IGM Biosciences Inc. traded 97% higher after the company reported FY/21 financial results and announced it entered into a collaborative partnership with Sanofi SA to develop six ...

@megtirrell shared
On Mar 31, 2022
Some background on drugmaker attempts to target another sodium channel, Nav1.7, and the genetic work behind it (many of those programs failed): https://t.co/9zfWG7wWjC
Open
Rare genes yield new hope for managing pain without opioids

Rare genes yield new hope for managing pain without opioids

Steve Pete and Reid Millius, with mirror-image genetic mutations, are helping companies develop better pain medicines.

Read more: Healthcare
weekly 05.04.2022
View archives
Back to home

Subscribe to Biotech - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy